FdaApplication
NDA 204251
Identifiers
- fda_app_no: NDA204251
Properties
| Property | Value |
|---|---|
| applicant_name | ALCON LABORATORIES INC |
| application_type | NDA |
| approval_date | 2013-04-19 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SIMBRINZA | BRIMONIDINE TARTRATE; BRINZOLAMIDE | 0.2%;1% | SUSPENSION/DROPS;OPHTHALMIC |
1 product